Cutting off cancer cells’ access to fat may help a specific type of cancer treatment work more effectively, reports a study by Van Andel Institute scientists.
Veracyte to buy C2i Genomics for up to $95M, includes $70M upfront
In announcing plans on Monday to pay up to $95 million for C2i Genomics, Veracyte is betting that it will expand further along the cancer